PE43695A1 - Agente antitrombotico peptidico - Google Patents

Agente antitrombotico peptidico

Info

Publication number
PE43695A1
PE43695A1 PE1994250437A PE25043794A PE43695A1 PE 43695 A1 PE43695 A1 PE 43695A1 PE 1994250437 A PE1994250437 A PE 1994250437A PE 25043794 A PE25043794 A PE 25043794A PE 43695 A1 PE43695 A1 PE 43695A1
Authority
PE
Peru
Prior art keywords
peptidic
antithrombotic agent
arginine
aldehyde
perhydroisoquinolin
Prior art date
Application number
PE1994250437A
Other languages
English (en)
Inventor
Robert Theodore Shuman
Paul David Gesellchen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE43695A1 publication Critical patent/PE43695A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A UN DERIVADO DE ALDEHIDO DE DIPEPTIDO DE L-PROLINA-L-ARGININA, DE FORMULA I, DONDE A ES ISOQUINOLINA, COMO (1R, 4aR, 8aR)-1,2,3,4,5,6,7,8-PERHIDROISOQUINOLIN-1-CARBONIL-(L)-PROLINIL-(L)-ARGININA ALDEHIDO; EL CUAL PUEDE SER UTIL COMO ANTICOAGULANTE AL SER UN INHIBIDOR DE TROMBINA
PE1994250437A 1993-09-14 1994-09-12 Agente antitrombotico peptidico PE43695A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/121,134 US5430023A (en) 1990-09-28 1993-09-14 Tripeptide antithrombotic agents

Publications (1)

Publication Number Publication Date
PE43695A1 true PE43695A1 (es) 1995-12-09

Family

ID=22394776

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994250437A PE43695A1 (es) 1993-09-14 1994-09-12 Agente antitrombotico peptidico

Country Status (31)

Country Link
US (1) US5430023A (es)
EP (1) EP0643073B1 (es)
JP (1) JPH07149791A (es)
KR (1) KR100312388B1 (es)
CN (1) CN1055698C (es)
AT (1) ATE160574T1 (es)
AU (1) AU674773B2 (es)
BR (1) BR9403542A (es)
CA (1) CA2131982C (es)
CO (1) CO4290364A1 (es)
CY (1) CY2072B1 (es)
CZ (1) CZ286139B6 (es)
DE (1) DE69407006T2 (es)
DK (1) DK0643073T3 (es)
ES (1) ES2110186T3 (es)
FI (1) FI944231A (es)
GR (1) GR3026115T3 (es)
HU (1) HU220620B1 (es)
IL (1) IL110933A (es)
MY (1) MY112879A (es)
NO (1) NO310240B1 (es)
NZ (1) NZ264438A (es)
PE (1) PE43695A1 (es)
PH (1) PH31655A (es)
PL (1) PL176448B1 (es)
RU (1) RU2105010C1 (es)
SI (1) SI0643073T1 (es)
TW (1) TW275622B (es)
UA (1) UA32556C2 (es)
YU (1) YU54194A (es)
ZA (1) ZA947015B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760235A (en) * 1992-03-04 1998-06-02 Gyogyszerkutato Intezet Kft. Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
JPH09509943A (ja) * 1994-03-04 1997-10-07 イーライ・リリー・アンド・カンパニー 抗血栓剤
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5691356A (en) * 1994-03-21 1997-11-25 Bristol-Myers Squibb Company Disubstituted heterocyclic thrombin inhibitors
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
JP3539607B2 (ja) * 1997-02-19 2004-07-07 シャープ株式会社 空気調和機の運転制御システム
JP2001525823A (ja) 1997-05-15 2001-12-11 イーライ・リリー・アンド・カンパニー 抗血栓化合物
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6172081B1 (en) 1999-06-24 2001-01-09 Novartis Ag Tetrahydroisoquinoline 3-carboxamide derivatives
JP4373792B2 (ja) * 2002-02-11 2009-11-25 ゴールド−ティー テック インコーポレイテッド 血栓形成を予防する方法
US7205315B2 (en) 2003-09-27 2007-04-17 Sanofi-Aventis Deutschland Gmbh Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
CN102391360B (zh) * 2011-11-02 2013-07-03 东南大学 一种抗血栓和血小板聚集的小肽
KR102388531B1 (ko) * 2021-07-07 2022-04-21 이재호 특장차용 스마트 유압 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
DE3827415A1 (de) * 1988-08-12 1990-02-15 Behringwerke Ag Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents

Also Published As

Publication number Publication date
MY112879A (en) 2001-10-31
HUT67849A (en) 1995-05-29
YU54194A (sh) 1997-01-08
US5430023A (en) 1995-07-04
RU2105010C1 (ru) 1998-02-20
CZ286139B6 (cs) 2000-01-12
BR9403542A (pt) 1995-06-20
KR100312388B1 (ko) 2001-12-28
CN1055698C (zh) 2000-08-23
PL305009A1 (en) 1995-03-20
IL110933A0 (en) 1994-11-28
NZ264438A (en) 1996-06-25
ZA947015B (en) 1996-03-12
FI944231A (fi) 1995-03-15
UA32556C2 (uk) 2001-02-15
HU220620B1 (hu) 2002-03-28
DE69407006T2 (de) 1998-04-16
KR950008534A (ko) 1995-04-19
TW275622B (es) 1996-05-11
NO943402D0 (no) 1994-09-13
JPH07149791A (ja) 1995-06-13
HU9402626D0 (en) 1994-11-28
ATE160574T1 (de) 1997-12-15
GR3026115T3 (en) 1998-05-29
SI0643073T1 (en) 1998-08-31
PH31655A (en) 1999-01-12
CO4290364A1 (es) 1996-04-17
DE69407006D1 (de) 1998-01-08
EP0643073B1 (en) 1997-11-26
IL110933A (en) 1998-12-27
ES2110186T3 (es) 1998-02-01
RU94034734A (ru) 1996-07-20
DK0643073T3 (da) 1997-12-29
CN1106819A (zh) 1995-08-16
NO943402L (no) 1995-03-15
AU7294894A (en) 1995-03-30
NO310240B1 (no) 2001-06-11
AU674773B2 (en) 1997-01-09
FI944231A0 (fi) 1994-09-13
EP0643073A1 (en) 1995-03-15
CA2131982A1 (en) 1995-03-15
CA2131982C (en) 2003-07-29
CY2072B1 (en) 1998-09-11
PL176448B1 (pl) 1999-05-31
CZ222094A3 (en) 1995-03-15

Similar Documents

Publication Publication Date Title
PE43695A1 (es) Agente antitrombotico peptidico
ATE76875T1 (de) Pentasaccharide.
EA199900301A2 (ru) Замещенные трициклические соединения
AU591860B2 (en) Pyrolidineamide derivative having anti-prolyl endopeptidase
ES2176262T3 (es) Acido 2-arilalquil-o arilalquenil-ciclopentano heptenoico, y derivados como agentes terapeuticos.
CO4940436A1 (es) Derivados de 5´-desoxicitidina y proceso de fabricacion de los mismos
ES2028121T3 (es) Procedimiento de (co)dimerizacion de un acrilato de alquilo inferior y composicion catalitica.
IS5497A (is) Bífenýlamidínafleiður
ATE92960T1 (de) Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.
GR3024588T3 (en) Use of modified heparin cofactor II
ATE86960T1 (de) Cyclopropanderivate.
DK0458387T3 (da) Isochromanderivater
DE68928767T2 (de) Imido-percarbonsäuren
CO5040090A1 (es) Inhibidores de proteasas
ATE12788T1 (de) Klebstoffe und dichtungsmassen.
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES2044241T3 (es) Procedimiento para la obtencion de esteres del acido acrilico y fungicidas que les contienen.
CO4750674A1 (es) Inhibidores de hidrazil-, bis-hidrazil-y bis-aminometil-car- bonil-proteasas
TW427998B (en) Steroid esters, process for their production and their pharmaceutical use
MX9702486A (es) La fabricacion de levobupivacaina y sus analogos de l-lisina.
JPS57197258A (en) Sulfonic ester derivative and its preparation
JPS5412384A (en) Carbostyril derivative
HUP9701782A2 (hu) Monomer biciklo[2.2.2]2.3:5.6-dibenzo-oktadién-(2.5)-7-karbonsav-alkenil-észterek és kopolimerizátumaik
GEP19971039B (en) Method for production of acrylic acid
SU1351062A1 (ru) Производные шестичленных циклических эфиров, ингибирующие рост золотистого стафилококка

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed